Banner Portal
Orthognathic surgery in a patient with von Willebrand disease


von Willebrand disease
Orthognathic surgery
Case reports

How to Cite

Barcellos BM, Moreira AG, Silveira ITT da, Gomes E de F, Xavier CB, Chagas Júnior OL. Orthognathic surgery in a patient with von Willebrand disease: case report. Braz. J. Oral Sci. [Internet]. 2024 Jan. 29 [cited 2024 Jun. 14];23(00):e241965. Available from:


Aim: This study aims to report the perioperative management of a patient with von Willebrand disease (vWd) who underwent orthognathic surgery. The report follows the guidelines of the Case Report Guidelines (CARE) and focuses on the steps taken to prevent bleeding during the surgical procedure. Methods: A 39-year-old female patient with skeletal Class III was treated with maxillary advancement and mandibular setback. Despite normal test results for ristocetin cofactor activity, measures were taken to prevent bleeding, including atraumatic surgical techniques, use of antifibrinolytic medication, induced hypotension during anesthesia, and preparation of blood products for transfusion during trans and postoperative periods if needed. In the end, these measures were not required. Results: The patient did not experience any bleeding during the surgical procedure or postoperative period, demonstrating the effectiveness of the measures taken to manage their blood dyscrasia. Two years after the surgery, the patient had satisfactory aesthetic and functional results and no evidence of relapse. Conclusion: Thus, this case report demonstrates that vWd does not prevent largescale oral and maxillofacial surgeries such as orthognathic surgery as long as proper precautions are taken pre-, intraand postoperatively.


Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000 Aug;84(2):160-74.

Keeney S, Cumming AM. The molecular biology of von Willebrand disease. Clin Lab Haematol. 2001 Aug;23(4):209-30. doi: 10.1046/j.1365-2257.2001.00400.x.

Sadler JE. Biochemistry and genetics of von Willebrand factor. Ann Rev Biochem. 1998;67:395-424.

Wilde JT, Cook RJ. von Willebrand disease and its management in oral and maxillofacial surgery. Br J Oral Maxillofac Surg. 1998 Apr;36(2):112-8. doi: 10.1016/s0266-4356(98)90178-4.

Zulfikar B, Koc B, Ak G, Dikici F, Karaman İ, Atalar AC, et al. Surgery in patients with von Willebrand disease. Blood Coagul Fibrinolysis. 2016 Oct;27(7):812-6. doi: 10.1097/MBC.0000000000000500.

Olsen JJ, Skov J, Ingerslev J, Thorn JJ, Pinholt EM. Prevention of bleeding in orthognathic surgery--a systematic review and meta-analysis of randomized controlled trials. J Oral Maxillofac Surg. 2016 Jan;74(1):139-50. doi: 10.1016/j.joms.2015.05.031. Erratum in: J Oral Maxillofac Surg. 2017 Sep;75(9):2027-2030.

Mei A, Qiu L. The efficacy of tranexamic acid for orthognathic surgery: a meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg. 2019 Oct;48(10):1323-8. doi: 10.1016/j.ijom.2018.07.027.

Varol A, Basa S, Ozturk S. The role of controlled hypotension upon transfusion requirement during maxillary downfracture in double-jaw surgery. J Craniomaxillofac Surg. 2010 Jul;38(5):345-9. doi: 10.1016/j.jcms.2009.10.012.

Ilankovan V, Blesing NE, Moos KF, Davidson JF. Correction of facial deformities in patients with mild bleeding disorders: a report of three cases. Br J Oral Maxillofac Surg. 1990 Dec;28(6):398-400. doi: 10.1016/0266-4356(90)90038-m.

Nickles K, Wohlfeil M, Alesci S, Miesbach W, Eickholz P. Comprehensive treatment of periodontitis in patients with von Willebrand disease. J Periodontol. 2010 Oct;81(10):1432-40. doi: 10.1902/jop.2010.100076.

Malmquist JP. Complications in oral and maxillofacial surgery: management of hemostasis and bleeding disorders in surgical procedures. Oral Maxillofac Surg Clin North Am. 2011 Aug;23(3):387-94. doi: 10.1016/j.coms.2011.04.006.

van Galen KP, Engelen ET, Mauser-Bunschoten EP, van Es RJ, Schutgens RE. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. Cochrane Database Syst Rev. 2019 Apr;4(4):CD011385. doi: 10.1002/14651858.CD011385.pub3.

O'Donnell JS, Lavin M. Perioperative management of patients with von Willebrand disease. Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):604-9. doi: 10.1182/hematology.2019000065.

Piñeiro-Aguilar A, Somoza-Martín M, Gandara-Rey JM, García-García A. Blood loss in orthognathic surgery: a systematic review. J Oral Maxillofac Surg. 2011 Mar;69(3):885-92. doi: 10.1016/j.joms.2010.07.019.

Yu CN, Chow TK, Kwan AS, Wong SL, Fung SC. Intra-operative blood loss and operating time in orthognathic surgery using induced hypotensive general anaesthesia: prospective study. Hong Kong Med J. 2000 Sep;6(3):307-11.

Dhariwal DK, Gibbons AJ, Kittur MA, Sugar AW. Blood transfusion requirements in bimaxillary osteotomies. Br J Oral Maxillofac Surg. 2004 Jun;42(3):231-5. doi: 10.1016/j.bjoms.2003.11.001.

McNulty S, Sharifi-Azad S, Farole A. Induced hypotension with labetalol for orthognathic surgery. J Oral Maxillofac Surg. 1987 Apr;45(4):309-11. doi: 10.1016/0278-2391(87)90349-1.

Praveen K, Narayanan V, Muthusekhar MR, Baig MF. Hypotensive anaesthesia and blood loss in orthognathic surgery: a clinical study. Br J Oral Maxillofac Surg. 2001 Apr;39(2):138-40. doi: 10.1054/bjom.2000.0593.

Carlos E, Monnazzi MS, Castiglia YM, Gabrielli MF, Passeri LA, Guimarães NC. Orthognathic surgery with or without induced hypotension. Int J Oral Maxillofac Surg. 2014 May;43(5):577-80. doi: 10.1016/j.ijom.2013.10.020.

Yawn B, Nichols WL, Rick ME. Diagnosis and management of von Willebrand disease: guidelines for primary care. Am Fam Physician. 2009 Dec 1;80(11):1261-8.

Petrovich CT, Drummond JC. [Hemoterapia e hemostasia], In: Barash PG, Cullen BF, Stoelting RK. [Anestesia Clínica]. 4. ed. São Paulo: Manole; 2004. p.201-8. Portuguese

Flores RPG, Bagatini A, Santos TL, Gomes CR, Fernandes MS, Molon RP. Hemophilia and anesthesia. Braz J Anesthesiol. 2004;54(6):865-71. doi: 10.1590/S0034-70942004000600017.

Kim SG, Park SS. Incidence of complications and problems related to orthognathic surgery. J Oral Maxillofac Surg. 2007 Dec;65(12):2438-44. doi: 10.1016/j.joms.2007.05.030.

Barbosa FT, Cunha RM, Barbosa LT. Von Willebrand’s disease and anesthesia. Braz J Anesthesiol. 2007;57(3):315-23. doi: 10.1590/S0034-70942007000300010.

Dolman RM, Bentley KC, Head TW, English M. The effect of hypotensive anesthesia on blood loss and operative time during Le Fort I osteotomies. J Oral Maxillofac Surg. 2000 Aug;58(8):834-9; discussion 840. doi: 10.1053/joms.2000.8194.

Grando TA, Puricelli E, Chiao IU, Mesquita DIC. [Hipotensão induzida e controlada pelo halotano e nitroprussiato de sódio na cirurgia ortognática]. Rev Bras Anestesiol. 1990;40(5):325-30. Portuguese.

Schaberg SJ, Kelly JF, Terry BC, Posner MA, Anderson EF. Blood loss and hypotensive anesthesia in oral-facial corrective surgery. J Oral Surg. 1976 Feb;34(2):147-56.

Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008 Mar;14(2):171-232. doi: 10.1111/j.1365-2516.2007.01643.x.

Kouides PA, Byams VR, Philipp CS, Stein SF, Heit JA, Lukes AS, et al. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol. 2009 Apr;145(2):212-20. doi: 10.1111/j.1365-2141.2009.07610.x.

Espitalier F, Remerand F, Dubost AF, Laffon M, Fusciardi J, Goga D. Mandibular nerve block can improve intraoperative inferior alveolar nerve visualization during sagittal split mandibular osteotomy. J Craniomaxillofac Surg. 2011 Apr;39(3):164-8. doi: 10.1016/j.jcms.2010.04.015.

Pagotto LEC, de Santana Santos T, de Vasconcellos SJA, Santos JS, Martins-Filho PRS. Piezoelectric versus conventional techniques for orthognathic surgery: Systematic review and meta-analysis. J Craniomaxillofac Surg. 2017 Oct;45(10):1607-13. doi: 10.1016/j.jcms.2017.06.011.

Alrefai M, Daboul A, Fleischhacker B, Landes C. Piezoelectric versus conventional techniques for orthognathic surgery: Systematic review and meta-analysis. J Stomatol Oral Maxillofac Surg. 2022 Oct;123(5):e273-8. doi: 10.1016/j.jormas.2021.12.005.

Spinelli G, Lazzeri D, Conti M, Agostini T, Mannelli G. Comparison of piezosurgery and traditional saw in bimaxillary orthognathic surgery. J Craniomaxillofac Surg. 2014 Oct;42(7):1211-20. doi: 10.1016/j.jcms.2014.02.011.

Rossi D, Romano M, Karanxha L, Baserga C, Russillo A, Taschieri S, et al. Bimaxillary orthognathic surgery with a conventional saw compared with the piezoelectric technique: a longitudinal clinical study. Br J Oral Maxillofac Surg. 2018 Oct;56(8):698-704. doi: 10.1016/j.bjoms.2018.07.011.

Echahdi H, El Hasbaoui B, El Khorassani M, Agadr A, Khattab M. Von Willebrand's disease: case report and review of literature. Pan Afr Med J. 2017 Jun;27:147. doi: 10.11604/pamj.2017.27.147.12248.

James PD, Goodeve AC. von Willebrand disease. Genet Med. 2011 May;13(5):365-76. doi: 10.1097/GIM.0b013e3182035931.

Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009 Dec;37(12):3124-57. doi: 10.1097/CCM.0b013e3181b39f1b. Erratum in: Crit Care Med. 2010 Jul;38(7):1621.

Goodnough LT, Panigrahi AK. Blood transfusion therapy. Med Clin North Am. 2017 Mar;101(2):431-47. doi: 10.1016/j.mcna.2016.09.012.

Aubron C, Aries P, Le Niger C, Sparrow RL, Ozier Y. How clinicians can minimize transfusion-related adverse events? Transfus Clin Biol. 2018 Nov;25(4):257-61. doi: 10.1016/j.tracli.2018.08.158.

Mital A. Acquired von Willebrand Syndrome. Adv Clin Exp Med. 2016 Nov-Dec;25(6):1337-44. doi: 10.17219/acem/64942.

Federici AB. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Semin Hematol. 2006 Jan;43(1 Suppl 1):S48-58. doi: 10.1053/j.seminhematol.2005.11.003.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Bhárbara Mariano Barcellos, Andressa Goicochea Moreira, Isabela Toledo Teixeira da Silveira, Eduardo de Freitas Gomes, Cristina Braga Xavier, Otacílio Luiz Chagas Júnior


Download data is not yet available.